# An Expanded Access Study to Assess Brensocatib for Participants With Non-Cystic Fibrosis Bronchiectasis

> **NCT05344508** · — · APPROVED_FOR_MARKETING · sponsor: **Insmed Incorporated**

## Conditions studied

- Non-Cystic Fibrosis Bronchiectasis

## Interventions

- **DRUG:** Brensocatib

## Key facts

- **NCT ID:** NCT05344508
- **Lead sponsor:** Insmed Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05344508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05344508, "An Expanded Access Study to Assess Brensocatib for Participants With Non-Cystic Fibrosis Bronchiectasis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05344508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*